COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INIBITORS
摘要
<p>The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to beat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of c-kit, PDGFR (alpha) and PDGFRl (beta) kinases. Formula (I).</p>
